Showing posts with label Healthcare. Show all posts
Showing posts with label Healthcare. Show all posts

Thursday, April 30, 2020

Projecting Deaths from COVID-19 (another update)


On April 2, I published a blog (here) analyzing available information to put into context the 100,000–240,000 U.S. COVID-19 deaths then being projected. On April 15, in this blog, I cast doubt on the reduction of government projections to “only” 60,000 deaths through August 4[i], suggesting that 100,000 deaths were more likely. The official projection has now been increased several times and as of this writing sits at nearly 73,000. Once again, applying my naïve methodology, I think this number is too low.

A chart I have found helpful to visualize the path of U.S. COVID-19 cases is to compare us to Spain, Italy, and Germany, recognizing that Italy started about two weeks before us and Germany and Spain a week after that.

Note: the horizontal axis is time (Italy has 64 days, the other countries fewer.

The most recent two weeks have crushed any chance the U.S. curve would flatten faster than Italy’s. Instead, our path is not even flattening as much as Italy’s did at comparable points in time. We have set our own course and it appears it will remain above Italy’s level of infection.

Fortunately, the death rate experienced in the U.S. is considerably lower than Italy’s. Using the metric developed in earlier posts of dividing total reported deaths by total reported cases a week earlier (in order to reflect an average time between reporting and death, should it occur), the U.S. is now at 7.3%, less than half Italy’s rate. The chart below demonstrates that both rates have been declining very slowly for some time.


Before combining the data from these charts to project future deaths, we need to examine some assumptions.

Why Are U.S. cases as a percentage of population increasing faster than Italy?

Either (1) U.S. testing is more comprehensive than was the case in Italy, resulting in more “benign” cases per capita detected in the U.S. than in Italy. AND/OR

(2) Italy did a better job of controlling the spread of the virus through the strength of and/or compliance with stay-at-home orders, business closures, and similar precautions.

If U.S. testing had significantly increased, yielding many “benign” cases, we would expect mortality rates of those infected to decrease. Over the last two weeks there has been a slight decline in the U.S. from 7.5% to 7.3%. If the explanation for the decreased death rate were entirely due to increased testing, it would mean that about 22,000 of the 412,000 cases reported between one and three weeks ago resulted from increased testing. Adjusting U.S. reported cases by that amount only slightly decreases the slope of the U.S. curve displayed in the first graph.

If next week we see a significant decline in the death rate, we’ll know increased testing is driving the level of newly reported cases. That would be a good thing.

In the U.S., states have imposed various levels of business closings and stay-at-home orders, making it difficult to compare to Italy, which did have different rules for the northern and southern sections of that country. I don’t have data to know how well Italians complied with their government’s rules. Anecdotal evidence in the U.S. shows compliance has been spotty. Some churches remained open despite state rules against crowds larger than ten people Demonstrations occurred in several state capitals protesting the “unnecessary” sheltering in place. Beaches in some states remain busy, where other states have kept them closed.

My current projections

As I write this (the morning of April 30), the U.S. has reported 1,064,194 COVID-19 cases of whom 61,656 have died. If we had no additional cases and the death rate remained at its current level, we’d have 77,000 deaths (4,000 higher than the government’s projections that go out to a later date).

If we continue to track Italy’s path (but recognizing our current level is higher than theirs) we would experience another 290,000 cases, which would yield another 21,000 deaths for a total of 98,000 by May 15. However, I do suspect death rates will continue to decline as they have in Italy. Should they decrease in the U.S. to 7%, the expected deaths by May 15 becomes fewer than 95,000—still much higher than the government’s estimate of 73,000 by August 4.

Italy continues to report new cases, and so will the U.S. We don’t know the effect warmer weather will have on stopping or slowing the spread. It happens for flu, so we can hope. Offsetting that are whatever negative effects may result from states “reopening” their economies by relaxing the disease-preventing rules currently in place.

I’m starting to think 100,000 deaths might prove optimistic, but I continue to hope I’m wrong.


Friday, March 27, 2020

The COVID-19 Trajectory


On Thursday, March 26, the United States took over the top spot for the number of reported COVID-19 cases, exceeding 85,000. It’s important to recognize that reported cases are an inaccurate proxy for actual cases. Some countries may deliberately under-report their rate of infection. Some countries do more testing than others. Regardless of the statistic’s flaws, it’s what we have available.

Being number one is not a status we’d prefer, but it’s one we are likely to keep for a time. Ultimately, India, with its population four times larger than ours, or Indonesia, Brazil, Pakistan, Nigeria, Bangladesh or similar with lesser populations but less-developed healthcare could exceed our overall cases. We don’t wish it on anyone.

Using Reported Cases per Million of Population

Because of the population differences, the raw number of cases does not reflect the status of the disease within a country. Ten-thousand cases in a country of ten million is much more serious than ten thousand cases in a country of one-hundred million. Converting the raw reported numbers into cases per million of population eliminates the effect of population size.

All statistics used in this blog come from https://www.worldometers.info/coronavirus/. I have not attempted to independently verify their numbers, but I believe them to be reliable. As of March 26, the U.S. had a reported case rate of 258 per million. Italy stood at 1,333; Spain at 1,236, Germany at 524. Some countries we don’t hear about in the news have much higher rates: Iceland stands at 2,350 and Luxembourg at 2,321.

The U.S. Prognosis if it follows other country trends.

We are in the early stages of this contagion’s spread. I prepared this chart to illustrate how our rate of reported cases compares with Italy and Germany. Day 1 for each country is the date when reported cases per million of population was approximately 6. Italy (in blue) reached that milestone first and, therefore, has the most days on the chart. Germany (salmon) reached the threshold eight days after Italy. The U.S. (black) had the benefit of an additional week before it crossed the threshold.

Covid-19 Reported Cases per Million Population: Italy, Germany, U.S.


Germany has closely tracked Italy for three weeks. That does not mean we know Germany will continue to follow Italy’s trend. Perhaps their “social distancing” measures will prove more effective, or their healthcare system more robust in stopping the spread of the disease by better testing and isolation of patients with positive coronavirus results.

The United States can take no comfort from this chart. Our rate of increase for the last week has exceeded Italy’s and Germany’s for their equivalent period.

What would it mean if we were to follow Italy’s trajectory? Using their 1,333 cases per million, the U.S. would total 440,000 reported cases at day 30. We would have about 33,000 new cases that day—Good Friday—two days before the President wishes for filled churches on Easter Sunday.

Will it be that bad?

I have no idea. Perhaps the measures many states have taken will be much more effective than Italy’s efforts, and we’ll see our rate of infection slow significantly. But it is also possible that because of the independent spirit Americans are so proud of, large pockets of the country will continue to ignore best medical precautions and our path will continue to worsen.

Below is the same chart, but with Spain added.

Covid-19 Cases per Million population: Italy, Germany, U.S. & Spain


Spain (green) reached the initial six cases per million on the same day as Germany. They did not implement the same precautions, and Spain’s rate per million has already exceeded Italy’s.

These charts should be a precautionary tale. In the U.S. we still have large portions of our population who continue to be exposed. Those working in our hospitals are most vulnerable: we bring the worst cases to them. That is the sharp tip, but underneath are all those who continue to serve so we may live. The folks at the grocery stores, drug stores, Amazon’s warehouses, factories producing masks and ventilators, police, fire, national guard. The list goes on.

We have not isolated those “out in the world” from those in “self-isolation.” That’s why infections are likely to continue for many more weeks. We can hope warm weather will help bring an end, but seeing cases rising in places like Australia and Chile, where summer recently moved to autumn, do not provide comfort.

Over the next days, facts will replace supposition concerning the trajectory of infections in the U.S. Rather than wishing and hoping for life to return to normal in two weeks, we need to concentrate on caring for those most ill and protecting those most vulnerable from contact with anyone infected.

This might be an appropriate time to live the words John F Kennedy used in his inaugural speech. “Ask not what your country can do for you; ask what you can do for your country.”

* * * * *

James M. Jackson authors the Seamus McCree series. Full of mystery and suspense, these thrillers explore financial crimes, family relationships, and what happens when they mix. False Bottom, the sixth and most recent novel in the series is set in the Boston area. You can sign up for his newsletter and find more information about Jim and his books at https://jamesmjackson.com.

Tuesday, March 24, 2020

What Are We Trying To Accomplish?


“The trouble with not having a goal is that you can spend your life running up and down the field and never score.” — Bill Copeland

“Without goals, and plans to reach them, you are like a ship that has set sail with no destination.” — Fitzhugh Dodson

The United States has not articulated a goal for dealing with the coronavirus that leads to COVID-19. Without clarity, we continue to mis-allocate and squander scarce resources and to sow distrust with conflicting information. In short, we will fail to reach our objective if we continue as a ship under full sail with no destination or compass.

The medical profession has proposed that our goal must be to flatten the curve of infection and provide extra resources so that our healthcare providers are not overwhelmed by the disease. The Trump administration has never accepted this objective.

Had that been the aim, the administration would have tried to slow contagion to buy time and use that respite to prepare for the coming tsunami of illness. It’s not that they didn’t know what to expect. Trump announced on January 31 that he was instituting some travel restrictions on individuals arriving from China. We won’t argue here whether the restrictions were too early or too late, too onerous or too lax. By the end of January, health officials knew the problem was serious enough to recommend restricting travel and Trump did.

In a globally connected world, no one could imagine that such restrictions would allow the U.S. to avoid contamination. By then, we already had several cases. What it could buy was time to prepare, time to buy some insurance. The thing about insurance is that you pay the premium and then hope like heck you never have to file a claim. We chose instead to wish for the best and not pay the insurance premium.

We should have ramped up production of masks. (One night of news from China showed that we’d need them.) By the end of January, we knew this disease required ventilators beyond our capacity. We should have ramped up production and storage. China was already building two additional hospitals Why weren’t we developing plans for providing more beds? So states and local government could react quickly when novel coronavirus made its appearance, we could have accelerated production of test kits and pre-distributed some portion to state health departments. We could have developed communication policies to educate residents on the danger, creating a language of short-term sacrifice for long-term benefit. I have seen no evidence we did anything of the sort.

The travel restrictions and decent luck bought us a month, and we pissed it away celebrating what a fine job we were doing and watching the DOW reach record highs.

In January and February, we did not have a goal to be prepared to control the novel coronavirus. Trump, on the campaign trail for re-election, dismissed any concerns over a pandemic and promoted his running of the economy: how low unemployment was, how high the stock market was.

Does that mean keeping our economy strong is the unstated goal? For some, it is. Florida’s governor refused to close beaches during Spring Break (although now he wants anyone visiting Florida from New York to self-quarantine for fourteen days!). Just this week, Texas Lt. Governor Dan Patrick suggested that grandparents should willingly risk death by COVID-19 “in exchange for keeping the America that all America loves for your children and grandchildren.” Obviously, healthcare is not something Patrick values as American. He wants us to “get back to work . . .get back to living . . .and those of us who are seventy-plus, we’ll take care of ourselves.”

This idea that what Americans value most is commerce is not a recent one. Calvin Coolidge said in a 1925 address to the American Society of Newspaper Editors that “The chief business of the American people is business. They are profoundly concerned with producing, buying, selling, investing and prospering in the world.”[i]

The question of the economic cost of saving lives is not abstract. We’d probably all agree that we wouldn’t send most people home for two weeks or longer to save one individual life. And we’d probably agree that if 100 million Americans would die because we didn’t shutter our economy, we close it down and count the bargain cheap. Easy answers at the extremes don’t eliminate tough choices in the middle.

That’s where having stated goals is useful. As many people have noted, we drive automobiles even though their use causes thousands of deaths and disabilities a year. Over time, Congress felt pressured and passed laws to make vehicles safer, but the convenience and economic advantages of automobile travel continue to be more important to us than the human toll of death and dismemberment autos cause.

With COVID-19, we have no shared vision of the tradeoff between economic well-being and increased mortality. If we agree that the only aim is to flatten the curve, we should take the approach of China and South Korea, test everyone and lock down the population. The hodge-podge of solutions at state and local levels when travel continues between areas can defeat even the best of intentions. Only national restrictions will work and only the federal government may do that. We’ve made shared sacrifices in times of war, but it’s important for leaders to demonstrate understanding. It does not help to propose social distancing and then see the President gather his team in close proximity for his daily update.

Despite Trump declaring himself a “wartime president” he has been ambivalent about calling for shared sacrifice and defining what that sacrifice must be. He declares that we will secure “total victory” over the virus without defining a path to success. Had he set clear objectives, Congress would have shared focus for its third try at bailing out portions of the economy, as it did with its first two slices at the pie. Without it, politicians (and their supporters) have retreated to their political tribal bunkers, squabbling over the same issues: corporations or people, broad-brush solutions or targeted remedies.

Dithering as a strategy in the face of a crisis is a recipe for disaster, and I fear we shall enjoy its bitter fruit. We cannot catch a time-machine and redo the past; we can only change the present and its effect on the future. I believe Americans will pull together if given a clear understanding of their required sacrifices and a believable assurance that the government will mitigate the damage as much as it can. Only one person has the positional power to make this happen.

President Trump must tell us his intentions. In clear, direct, unambiguous language, he must detail the goals he wants us to achieve. In November, voters can decide the wisdom of his proposed course and either reward him with four more years or vote him out of office. 



*     *     *     *     *

James M. Jackson authors the Seamus McCree series. Full of mystery and suspense, these thrillers explore financial crimes, family relationships, and what happens when they mix. False Bottom, the sixth and most recent novel in the series is set in the Boston area. You can sign up for his newsletter and find more information about Jim and his books at https://jamesmjackson.com.

Friday, March 13, 2020

Why Comparing COVID-19 to the Flu is Flawed


Comparison to the number of flu deaths (say 30,000 a year) and the current number of COVID-19 deaths misses several major points when viewed from a national or international level. Humans have been exposed to various flu viruses for many generations. Many have partial or full immunity to certain strains; large percentages of older folks in the U.S. get annual flu shots[i]. None of us has any immunity to COVID-19.

Flu spreads widely, but because of vaccines and partial immunity, slowly. Last year, the CDC estimated 35.5 million of us got sick with influenza, 16.5 went to a health care provider; 490,000 were hospitalized, and 34,000 died.[ii]

COVID-19 spreads rapidly through exposed populations. That explosive growth can (and did in China) overwhelm hospital facilities in any country. Some years of severe flu have also overwhelmed hospitals, but to a lesser extent than projections of what an unconstrained COVID-19 epidemic will cause.

Even if COVID-19 acted the same as flu it could cause an additional half million hospitalizations. At that level, the system is in trouble. But COVID-19 spreads faster than the flu (because of the lack of immunity) and is more deadly.

The death rates in a typical flu year are less than 1% for those over age 65. The COVID-19 death rate for the 50-59 group are estimated at 1.3%, for 60-69 at 3.6%, for 70-79 at 8% and for 80+ at 14.8%.[iii]

Now, project much higher rates of infection because of the virgin population, combined with much higher rates of mortality, and the resulting projection of deaths from an unconstrained COVID-19 is significantly higher than that from flu. Unless we moderate the speed of infection, our healthcare system will collapse under the weight of these additional illnesses. China may be able to build a hospital in a week, but in the U.S., we wouldn't even have the permit after a week's time.

Do extreme measures controlling population movements limit the number of cases? Maybe, but that is not the only objective of decreasing the opportunities for the virus to spread. One key from a public health perspective is to not overwhelm the health care system. An unconstrained virus infects a population very quickly and then is done because new hosts are no longer available. A constrained virus will take much longer to run its course, may or may not have the same overall exposure, but smooths out the number of infections over time--meaning the health care system has a much better chance of treating the ill.

Here's a graphical representation of this “flattening of the curve” taken from Vox:

CDC Graph of Effect of Flattening COVID-19 Infections

The flu has a naturally flattened curve because of immunity and vaccinations compared to COVID-19. As we have already seen in pockets of exposure, unchecked by social distancing precautions, COVID-19 spreads very rapidly.

Treating COVID-19 with the same disregard as we do the flu (Oh, it only kills 30,000 people a year.) will lead to a major healthcare crisis in the U.S. Aggressively acting to slow it down is important to all of us, even the younger generations who have little to personally fear from catching the disease.

Closing on a more hopeful note, Apple announced it has reopened all its stores in China.[iv] As the bad news continues to pile up, we should remember that this too shall pass.


*     *     *     *     *

James M. Jackson authors the Seamus McCree series. Full of mystery and suspense, these thrillers explore financial crimes, family relationships, and what happens when they mix. False Bottom, the sixth and most recent novel in the series is set in the Boston area. You can sign up for his newsletter and find more information about Jim and his books at https://jamesmjackson.com.

Thursday, March 12, 2020

It’s a Bear Market. Now What?


On March 11, 2020, the Dow officially entered a bear market when it closed at 23,553.22 more than 20% below it’s all-time high of 29,9551.42 on February 12, 2020. It took less than a month for the bear to appear, but bear markets are often quick and steep, whereas bull markets are longer, sustained rallies.

While the Dow gets the headlines, I prefer looking at the S&P 500, which is also on the precipice of reaching bear territory. This morning markets dropped 7% (and triggered a second circuit breaker pause this week). Unless the S&P 500 claws most of that loss back before the end of the day, it will also reach bear market status. Must it happen? No: five times since 1976, the S&P 500 has declined 19+%, but not reached the “magic” 20%-loss threshold. I wouldn’t bank on today being the day that makes this number six.

In my blog two days ago, I suggested, “Stock market volatility is caused by uncertainty” and “[the markets’] real concerns are the economic effects of government policies to contain the virus.”

Some of that uncertainty was cleared up during President Trump’s speech last night, but not much. The key takeaways are:
  •        To limit COVID-19 cases from entering the U.S., he’s suspending travel from Europe (excluding the U.K.) for 30-days.
  •         Health insurance carriers have agreed to not charge co-payments for COVID-19 treatments.
  •         The president has promised to take emergency action to provide financial relief for workers who are ill, quarantined, or caring for others due to coronavirus. He supplied no specifics regarding what this aid would look like or when he would take the action.
  •         He’s asking Congress to approve $50 billion of additional funding to the Small Business Administration to make low-interest loans.
  •         The IRS will extend tax-filing deadlines for undefined individuals and businesses (to temporarily provide additional liquidity to the system.
  •         He requested that Congress enact immediate payroll tax relief—something congressional leaders from both parties have already suggested has little chance of passing.

So why the negative reaction from the futures markets? I’m not them, so I can only guess (which is what they’re doing as well!). The major problem is that much of the uncertainty is unresolved, and what was resolved is not good news for corporations.

  •       The lack of specificity demonstrates the Federal government is still behind the curve, reacting instead of being proactive. How much financial relief can people expect? What will be the fiscal stimulus effect of the aid? How quickly will it appear? The speech felt like something the President had to do but didn’t want to do.
  •         That the president continued to push payroll tax relief is a negative reminder of Trump becoming fixated on his preferences and his inability to find larger, unifying solutions to issues.
  •         No announced agreement between the White House and the House of Representatives on legislation. (Sen. McConnell has already said the Senate will wait for legislation from the House.)
  •         No mention of targeted relief to affected industries: The 30-day ban on most European travelers will hit airlines, hotels/motels/resorts, restaurants, ridesharing, etc. The trickle-down effect will be significant.
  •         No mention by the president that kits will be available to test anyone who needs it. No assurances that the health care system is prepared for a surge of new cases or what the government is doing to help them prepare.
  •         And in after speech news, the NBA suspended their season after one of its players tested positive for coronavirus. (This after the NCAA announced March Madness games would take place in empty arenas.)

In short, we have reached a point in the U.S. virus cycle where most of the news will be bad. The drumbeat will be depressing, and more people will react by reining in the ways in which they physically interact with others. More areas of the country will experience their first case, bringing the disease closer to home for more people. Case numbers will rise, as will deaths.

More event cancellations will make the news. Businesses have already cut back on travel and meetings. One after another, colleges and universities are moving to online classes. Some, like Harvard, are trying to empty their dorms as much as possible. Actions taken in Washington State to restrict congregations of people will be adopted elsewhere as pockets of COVID-19 appear.

The certainty of negative outcomes has caused the market decline. The uncertainty will cause further market volatility—both up and down. Based on that, I don’t think we’ve yet seen the bottom of this market cycle.

Some clarity for the markets will occur when the House passes its legislation. That clarity may be good or bad for the markets, but my guess that soon after that, we are likely to see volatility begin to dampen.

*    *     *     *


James M. Jackson authors the Seamus McCree series. Full of mystery and suspense, these thrillers explore financial crimes, family relationships, and what happens when they mix. False Bottom, the sixth and most recent novel in the series is set in the Boston area. You can sign up for his newsletter and find more information about Jim and his books at https://jamesmjackson.com.

Thursday, March 2, 2017

A Primer on Replacing Obamacare

“For every complex problem, there is a solution that is clear, simple, and wrong.” – HL Menken

“Nobody knew that health care could be so complicated.” – President Donald J. Trump

For the last six years, congressional Republicans have had a clear, simple, and wrong solution to fixing the Affordable Care Act (ACA or “Obamacare”). They voted umpteen times to repeal it and offered no measure to replace it.

The law, as many laws are, is a complex compromise between aspiration (mostly by Democrats) and legislative reality. It was not perfect at birth and, like a six-year-old car that has had no maintenance, is in worse shape today. Had Republicans spent the last six years fixing the problems in Obamacare, it would be in much better shape. But that is all past. We must look to the future.

With Trump’s election as president, Republicans suddenly became the dog that caught the Obamacare car. What do they do with the thing? In my Open Letter to President-elect Trump and the Members of the 115th Congress (on repealing Obamacare) I closed with these words:

If you do not have sufficient experience with the actuarial and underwriting principles that underpin the individual insurance marketplace, I urge you to work with the American Academy of Actuaries to understand how those principles relate to any proposed legislation before casting your vote.

Perhaps had President Trump reflected on my open letter he would not have been so surprised about the complexity of health care.

Fortunately, Congressional leaders recognized that the wrong approach of repealing without replacing a law that runs to 906 pages (and tens of thousands of pages of regulations) would lead to multiple disasters. With healthcare, even the minutia has minutia.

However, there are several broad truths about heath care that are important to keep in mind as we evaluate the Republican’s proposed replacement.

The total cost of medical insurance =
the total cost of medical benefits provided, plus
administrative costs, plus
profit

To reduce the cost of medical insurance requires reducing some or all of its three components.

Reducing corporate profits is not part of the Republican (or Democratic) agenda.

Everyone would like to reduce administrative costs, which everyone agrees are too high. There are very few incentives in place to reduce administrative costs. Obamacare forced certain insurers to rebate to their policyholders a portion of paid premiums if overhead, including profits, exceeded 20% (15% in the large-employer market) of premiums collected. I received a rebate related to my premiums for 2015 from my large-deductible medical care policy.

Moving to a one-payer system would probably reduce administrative costs. It has for other countries; but the U.S. has its unique issues, so I am not making promises. Shifting policies to give consumers a larger choice of insurance options will not materially affect administrative costs—and may increase marketing costs.

Which leaves us with reducing medical costs as the only practical method to reduce overall premiums.

Reducing the cost of medical benefits provided can be achieved by
(a) reducing costs charged to patients or their intermediaries (insurance companies or the government),
(b) shifting the costs from covered insurance to some other source of payment, or
(c) eliminating utilization of the benefit.

Reducing Costs Charged: Competition without collusion usually reduces costs. Republican proposals to allow insurance carriers to operate over state borders could offer additional competition and marginally reduce administrative costs. (Insurance companies often must keep separate corporate entities and books for each state in which they operate.) Changing laws to provide greater competition on drug prices would address that aspect of cost. Three steps Congress could take to reduce drug costs incurred are to allow Medicare to negotiate costs with drug companies, to outlaw the ability of a drug patentholder from paying another company to withhold a generic from the market, and to allow the public to import drugs from other countries when they are the same drug sold at a lower price.

Regulating provider prices (as Congress has tried with Medicare reimbursement rates) often leads to shortages of providers when doctors make the economic decision to stop accepting Medicare patients and concentrate instead on private insurance payments.

Shifting Costs from Covered Insurance: One of the most popular approaches to reducing medical insurance premiums is to shift costs from the policy elsewhere. The two major approaches are to increase the policy deductible and to cap expense reimbursements.

Before I became Medicare eligible, I purchased high-deductible insurance. I was healthy and gambled that my out-of-pocket medical costs would be less than the insurance costs of a low-deductible plan. However, if something major happened, I didn’t want to pay for that out-of-pocket. My insurance costs were significantly reduced – BUT at the cost of taking on considerable risk. (My gamble paid off for the fourteen years I had individual coverage.)

My behavior was affected, however. I thought twice before going to a doctor or agreeing to a test or procedure. This is a double-edged sword. Because I had monetary skin in the game, I was a more careful consumer. However, studies have shown that when people defer routine healthcare, the long-term costs of chronic diseases increases because the individual enters the health care system at a more advanced stage.

The two ways of limiting reimbursement is to impose a lifetime maximum or reimburse fixed amounts for a particular benefit (for example $200/day in the hospital). As costs increase and reimbursement does not, more of the total costs are shifted from the plan to the covered individual. (The same will happen to states if they receive block grants. Unless Congress continues to increase the block grants to match cost increases, the states must either pick up the tab or cut benefits to those covered.)

Eliminating Benefit Coverage: There are multiple ways to decrease benefits and reduce costs. Health care policies could exclude certain procedures now covered. They could decide to eliminate coverage for organ transplants, or abortions and birth control, or sex-change procedures, or wellness exams, or any drug that costs over $1,000 a year, or whatever was deemed legal. The United States could effectively ration health care by limiting the number of procedures performed each year. This is the approach Canada has taken to reduce costs: fewer procedures equals lower costs.

Reducing the number of covered individuals: Finally, the easiest way to reduce costs is to reduce the number of individuals covered. Increase Medicare’s eligibility age to seventy from sixty-five and you’ve eliminated five years of costs. Eliminate medical coverage for Medicaid-eligible individuals, and cut those costs.

Obamacare increased overall covered costs by including additional benefits in plans, decreasing the acceptable size of deductibles in order to avoid a tax-penalty (I had to pay a penalty the first year because my high-deductible plan did not qualify), and significantly expanding the number of individuals covered under medical insurance by allowing children to remain much longer under their parents’ policy and expanding Medicaid edibility for those states who accepted it.

Republicans currently claim their proposal will decrease medical costs. The question that we need to answer is how will they do it? What are the tradeoffs they are proposing? Whose ox is gored?

The truth about pre-existing conditions

I pay house insurance every year and I hope to lose money every year because I don’t want my house to burn down just so I can win. Even though I have “lost” money on my housing insurance every year, it’s reasonably fair. Actuaries and underwriters price my insurance based on my house’s size, structure, safety measures, type of wiring, how far it’s away from a fire hydrant and fire station, and so on. They can reflect all the pre-existing conditions of my house in determining the premium.

In the past, we have done the same thing with individual medical insurance. If you are a young, healthy male, don’t smoke, do drugs, or engage in risky avocations (motocross racing, for example), your medical insurance can be inexpensive. Your biggest risk is from accidental injury; you rarely get sick. And you don’t get pregnant, which is why individual insurance for women used to cost more than for men.

Until as a society we decided that wasn’t fair, and eliminated sex as a basis for determining premiums. Men now subsidize women in this regard.

Many group medical insurance plans charge the same premium regardless of age. Older folks have more medical issues than younger ones. The young subsidize their elders. This is also the case for Medicare. Young(er) beneficiaries generally cost less than their older compatriots, yet premium costs are the same.

Even where plans reflect age in their premiums, they may not reflect health status. All Medicare beneficiaries pay the same premiums (ignoring extra premiums paid based on income status). Healthy beneficiaries subsidize sicker ones.

When we turn to the individual insurance market, healthy people think premiums should be based on their age and health. Why should they pay to cover someone who is older, or overweight, or has diabetes? It’s a fair question and one that needs an answer.

Under Obamacare, the answer was essentially that the young and healthy had to join plans and pay more than their fair share as part of a societal good. The same extra costs that are buried in group plans now became embedded in individual plans. Younger individuals either joined and paid these extra costs through their premiums or chose not to join and paid the costs through a tax. Because Obamacare provided a financial mechanism for supporting the extra costs of those with pre-existing conditions, they could require insurance companies to provide coverage for those sicker people. It was up to insurance companies to enroll enough of the younger, healthy individuals to break even on the deal.

What happens under such a system? The sick sign up in a New York minute: it’s a great deal for them. It’s up to insurance companies to enroll enough healthy folks to pay the tab for the sick ones. Insurance companies set rates based on an assumption of how many sick and healthy people they could attract. Where they were unable to enroll as many younger healthy individuals as they planned, they lost money. To make up for those losses, they raised premium rates. In those areas of the country where states supported the new marketplaces, lots of younger people joined the plans. Competition remains and premiums increases are moderate. Where states did not support the new marketplace, enrollment was well below expectations, resulting in subsequent huge rate increases and carriers dropping out of the market.

The death spiral of individual plans

Those of us involved in employer group medical insurance saw this death spiral when employers first introduced optional higher-deductible plans in an attempt to lower their insurance costs. Back in the 1970s and early 1980’s, most plans had no or very small ($100 individual/$300 family) deductibles. Increasing the deductible to $250 or $500 produced significant savings relative to the costs at the time. Employees chose the plan that made the most economic sense to them. Healthy individuals and families rushed to the higher-deductible plans. Older and sicker individuals stayed with the old no-deductible plans.

At the same time, companies first introduced Flexible Spending Accounts, seeding them with money for those employees choosing the higher-deductible plans and allowing employees to set aside tax-free money to pay for the costs they would now need to pay out-of-pocket.

Note what employers did: they lowered plan costs and provided “tax credits” to help pay for the plans. The very same elements Republicans currently promote (although we do not yet know the details). How did that work?

The next year, the costs of the no-deductible plan increased significantly. It included sicker folks after all, and in the second year, those on the margin dropped their expensive coverage and selected the higher-deductible plan. Those folks in the high-cost plan were on average even sicker. In a short time, the high cost plan had astronomical premiums and the companies dropped those plans altogether.

Deductibles for everyone have continued to increase, as have premiums, but at least under the group plan concept, those with pre-existing conditions can still receive coverage, and that coverage is subsidized by their fellow employees.

Take the same scenario to the individual market and no such protection will exist for those with pre-existing conditions. With multiple insurance plans to choose from, the healthy will make economic decisions that will cause people with pre-existing conditions to experience that same cost death spiral. Sure, they won’t be denied insurance, but they won’t be able to afford it.

Squeeze the Balloon

Visualize medical costs as a balloon. Each new drug, each new treatment, each new test, each new procedure, each administrative change either blows more air into the balloon or lets a little out. Total U.S. medical expenses only decrease if we find ways to let air out of the balloon. Squeezing the balloon simply shifts who pays for it and makes the one doing the squeezing “good” by pushing costs away from their sector of the balloon.

Propositions such as changing Medicare from a single-payer system to a system in which all covered members receive a credit grant to allow them to shop for their own insurance does not affect the size of the balloon. It will affect who pays the costs, and, depending on its implementation, may create its own death spiral similar to the corporate experience of the 1970s and 1980s. Block grants shift responsibility and burdens from the Federal government and introduce additional inequities between states.

Conclusion

Above all, ignore the pretty words (and titles) politicians use to describe their laws.

When evaluating health care proposals, consider the specifics: how costs are being reduced, who will subsidize whom and by how much, and what incentives will counteract the inherent inequities in paying for medical plan costs.


~ Jim

Friday, August 30, 2013

A Discussion About Obamacare


During a recent bridge tournament I enjoyed dinner with several of my teammates and friends. I have no idea exactly how it happened, but the talk turned to Obamacare. The initial statement tossed out to the table was something to the effect that “Obamacare will bankrupt the country.” Since at least two of the seven sharing dinner did not agree at all with that statement (including yours truly) the result could have been (1) a heated argument between opposing sides, (2) those who did not agree chose to remain silent, or (3) an interesting discussion where both sides might learn from the other.

I stepped into the breach and asked why the person thought that was true. His answer included the current deficits and health care costs that continue to increase uncontrollably. I agreed those issues were major problems, but suggested they were attributable much more to Medicare and Medicaid than to the Affordable Care Act, aka Obamacare.
I suspect it was in part the fact that I agreed there was a problem that allowed us to explore the sources of the problem and solutions that might work. It also allowed those who were small business owners to educate the rest of us on how they will have to respond to the law.

The first charge against Obamacare was that more people would be insured and therefore the costs would increase. I used my own situation as an example to suggest why that wasn’t quite accurate. I carry a high-deductible policy, which, unless I become very ill, will never pay me a cent. The benefit I reap even if no medical catastrophe arises is that the insurance company negotiates the cost of my medical care. I am not stuck paying the full “sticker” price for the services I use.

There are three major systemic problems with the roughly 1 in 7 Americans who are uninsured. First, partly because they have no insurance, they skimp on preventative care. They roll the dice and hope they don’t come up snake-eyes. Second, if they do get a bad roll of the dice, they tend to utilize the most expensive medical care option, the emergency room, because they will not be turned away. Lastly, because they are uninsured, they are charged “full-rates.” That is, they do not have an insurance company between them and the provider to negotiate fees.

Obamacare addresses two of the three problems. People currently uninsured will be able to obtain insurance that provides preventative care, and the insurance companies will negotiate on behalf of their policyholders. These are serious problems. Over 60% of personal bankruptcies are caused by medical issues (that includes medical costs and loss of work). Unfortunately, because universal coverage is not provided under the Affordable Care Act, not all uninsured will choose coverage. However, even if only half become covered, it will make a significant improvement.

The Affordable Care Act does not solve the problem of insufficient providers. Over the short term, it probably exacerbates the situation. Newly insured, just like people who become eligible for Medicare, have accumulated health issues that they want to immediately take care of. The provider shortage, I said, was largely caused by state licensing requirements issued by boards run by doctors. They act as a semi-closed society to keep out lots of qualified foreign-trained doctors, in order to keep fees high. Doctors are not unique; every profession does this, including my own: actuaries had a series of difficult exams, and I didn’t ever use most of the information covered by the exams, but it was a barrier to entry.

Someone objected that Obamacare would ration healthcare similar to the problems in Canada that cause Canadians to come to the U.S. for treatments. I said that if we were to control healthcare costs we would need to ration it. In my opinion we spend too much on extension of life without quality and too little on preventative care. Until we as a country have a serious discussion about those issues we wouldn’t get to the root of the problem. We could argue about how to make those decisions, but no one would disagree that we need to make them IF we choose to rein in costs.

One of the small-business owners said he had to change his staffing levels because of the costs of Obamacare. To stay competitive, he eliminated several permanent part-time positions and created a small number of full-time positions.

I acknowledged any major change would cause dislocations. Large corporations had already gone through their own staffing changes to reduce costs. Regardless of whether those changes were accomplished in order to maintain competitiveness (the corporate view) or to increase profitability (labor’s perspective), for the last twenty years corporations have moved people from benefit-qualifying positions to those without benefits. The most aggressive were now making many of their workers on-call, and expected them to be available regardless of how many hours they actually got to work.

The great thing about this conversation was it was a conversation. All of us sitting around the table are affected by and concerned about healthcare, but none of us were experts. (I had the most comprehensive background in healthcare costs and financing from my years of creating and determining costs of health care plans; the small-business owners knew what they were doing to accommodate changes.) At the end of the discussion we had all learned something we didn’t know before, and we did it through civil discussion.

If seven people from various economic and cultural backgrounds can accomplish that much over dinner, why can’t Congress?

~ Jim